期刊
JOURNAL OF CONTROLLED RELEASE
卷 334, 期 -, 页码 11-20出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2021.04.002
关键词
Nanocarriers; Nanoparticles; Biologics; Antibiotics; Sustained release; Pulmonary delivery
资金
- PhRMA Foundation
- Optimeos Life Sciences
This study introduces a scalable technique to encapsulate water-soluble therapeutics into polymeric nanocarriers, demonstrating improved therapeutic effect and reduced toxicity. The results establish the potential of this technique as a platform for nanocarrier delivery of water-soluble therapeutics, particularly in pulmonary administration.
Peptide and protein therapeutics generally exhibit high potency and specificity and are increasingly important segments of the pharmaceutical market. However, their clinical applications are limited by rapid clearance and poor membrane permeability. Encapsulation of the peptide or protein into a nano-scale carrier can modify its pharmacokinetics and biodistribution. This might be employed to promote uptake in desired cell types or tissues, to limit systemic exposure, or to reduce the need for frequent injections. We have recently described inverse Flash NanoPrecipitation (iFNP), a scalable technique to encapsulate water-soluble therapeutics into polymeric nanocarriers, and have demonstrated improvements in therapeutic loading of an order of magnitude over comparable approaches. Here, we describe the formulation parameters that control release rates of encapsulated model therapeutics polymyxin B, lysozyme, and bovine serum albumin from nanocarriers produced using iFNP. Using a neutropenic lung infection mouse model with a multi-drug resistant Acinetobacter baumannii clinical isolate, we demonstrate enhanced therapeutic effect and safety profile afforded by nanocarrier-encapsulated polymyxin B following pulmonary administration. The encapsulated formulation reduced toxicity observed at elevated doses and resulted in up to 2.7-log10 reduction in bacterial burden below that of unencapsulated polymyxin B. These results establish the promise of iFNP as a platform for nanocarrier delivery of water-soluble therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据